Moreover, it was recently suggested by Perez et al. that also TOPBP1 could act as a modifier gene in the development of PAH15 and it was thus included in subsequent PAH-specific NGS panels36. The gene discussed is TOPBP1; the disease is pulmonary arterial hypertension.